In an experimentally induced fulminant hepatic failure (FHF) model in rats, crocetin treatment suppressed the pro-inflammatory cytokines, oxidative stress and NF-κB activations [25]. This evidence concerns the gene NFKB1 and Fulminant hepatic failure.